Liver transplantation - A therapeutical mode with low priority in Norway?;Er levertransplantasjon et faglig underprioritert behandlingstilbud i Norge?

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 1, 1996, Pages 72-76

  Norheim, Ole Frithjof ^a,c   Bjøro, Kristian ^b   Schrumpf, Erik ^b   Søreide, Odd ^b  

^a Senter for medisinsk etikk   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Fylkessjukehuset pa Voss ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; EUROPE; HEALTH CARE PLANNING; HUMAN; LIVER TRANSPLANTATION; NORWAY;

EUROPE; HEALTH PRIORITIES; HUMANS; LIVER TRANSPLANTATION; NORWAY;

EID: 0030577540     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bjøro K, Schrumpf E, Bergan A, Flatmark A, Mathisen Ø, Sødal G et al. Levertransplantasjon i Norge. Tidsskr Nor Liegeforen 1996; 116: 19-24.
2. Bronsther O, Fung JJ, Izakis A, Van Thiel D, Starzl TE. Prioritization and organ distribution for liver transplantation. JAMA 1994; 271: 140-3.
3. Delmonico FL, Jenkins RL, Freeman R, Vacanti J, Bradley J, Dienstag JL et al. The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg 1992; 127: 579-84.
4. Bismuth H, Castaing G. European Liver Transplant Registry. Paris: Hopital Paul Brousse, 1993.
5. Keiding S. Nordisk Levertransplantasjons-register. Aarhus: Kommunehospitalet i Aarhus, 1994.
6. Keiding S. Prioritering ved organtransplantasjoner: levertransplantasjoner. Nord Med 1994; 109: 340-4.
7. Transplantasjoner i Norge. Omfang og fremtidig organisering. Helsedirektoratets utredningsserie 1-89. Oslo: Statens helsetilsyn (Helsedirektoratet), 1989.
8. Munson R. Intervention and Reflection. Basic issues in medical ethics. California: Wadsworth Publishing Company 1992: 37.
9. St.meld. nr. 50 (1994). Samarbeid og styring. Mål og virkemidler for en bedre helsetjeneste.
10. Eddy D. Should we change the rules for evaluating medical technologies? I: Gelinjs P, red. Modern methods of clinical investigation. Washington DC: National Academy Press 1990: 117-34.
11. Evensen SAE, Brinch L, Stavem P, Tjønnfjord G. Survival in 91 adults with acute myelogenous leukaemia treated with 1-6 intensive courses of chemotherapy. J Intern Med 1992; 232: 433-7.
12. Clift RA, Buckner CD, Appelbaum FR, Bearman SI, Petersen FB, Fisher LD et al. Allogenic bone marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867-71.
13. Brinch L, Evensen SA, Blomhoff JP, Albrechtsen D. Allogen beinmargstransplantasjon hos voksne pasienter med alvorlige blodsykdommer 1985-92. Tidsskr Nor Lægeforen 1993; 113: 3351-3.
14. Sokal J, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE et al Prognostic discrimination in «Good-Risk» chronic granulocytic leukemia. Blood 1984; 63: 789-99.
15. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Evaluating survival after allogenic bone marrow transplant for chronic myeloid leukaemia in chronic phase: a comparison of transplant versus no-transplant in a acohort of 258 patients first seen in Italy between 1984 and 1986. Br J Haematol 1993; 85: 292-9.
16. Marks DI, Cullis JO, Ward KN, Lacey S, Szydlo R, Hughes TP et al. Allogenic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. Ann Intern Med 1993; 119: 207-14.
17. Nordic Myeloma Study Group (NMSG) Protokoll # 5/1993. Intensivbehandling av yngre myelompasienter (< 60 år) med stamcellestöd. Lund: Universitetsklinikken i Lund, 1994.
18. Dune GM, Dixon DO, Carter S, Stephens R, Rivkin R, Bonnet J et al. Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest oncology group study. J Clin Oncol 1986; 4: 1227-37.
19. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibeth G, Rossi JF et al. High dose therapy in multiple myeloma: a prospective randomized study of the Intergroupe Francais du Myelome (IFM). Blood 1994; 84 (suppl 1): 1530.
20. Attal M, Huguet F, Schlaifer D, Payen C, Lassoued S, Laroche M et al. Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction therapy. Bone Marrow Transplant 1991; 8: 125-8.
21. Keiding S, Ericzon BG, Eriksson S, Flatmark A, Höckerstedt K, Isoniemi H et al. Survival after liver transplantation of patients with primary biliary cirrhosis in the Nordic countries. Scand J Gastroenterol 1990; 25: 11-8.
22. Benhamou JP. Indications for liver transplantation in primary biliary cirrhosis. Hepatology 1994; 20 (suppl): 11-3.
23. Krom RAF. Liver transplantation and alcohol: Who should get transplants? Hepatology 1994; 20 (suppl): 28-32.
24. Osoria RW, Freise CE, Ascher NL, Roberts JP, Avery M, Lake JR. Orthotopic liver transplantation for end-stage alcoholic liver disease. Transplant Proc 1993; 25: 1133-4.
25. Powell WJ jr., Klatskin G. Duration of survival in patients with Läennecs cirrhosis, influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968; 44: 406-20.
26. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 1986; 6: 129-37.
27. Williams R, Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology 1994; 20 (suppl): 5-10.
28. Markus BH, Dickson ER, Grambesch PM, Fleming TR, Mazzaferro V, Klintmalm GB et al. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989; 320: 1709-13.
29. Lucey MR, Merion RM, Henley KS, Campbell DA, Turcotte JG, Nostrant TT et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 1992; 102: 1736-42.
30. van Thiel DH, Wright HI, Fagiuoli S. Liver transplantation for hepatitis B virus-assoication cirrhosis: a progress report Hepatology 1994; 20 (suppl): 28-32.
31. Kristensen KOF, Jacobsen JE. Praktisk kostnadsanalyse av høykostnadsmedismen ved Rikshospitalet - hvordan verdsetter vi virksomheten? Tidsskr Nor Lasgeforen 1994; 114: 2505-9.
32. Friman S, Persson H, Henriksson BA, Norden G, Stenquist O, Wijneven AC et al. Levertransplantation - erfarenhetarna från de 100 första i Göteborg. Läkartidningen 1992; 89: 2203-6.
33. Levy MF, Jennings L, Abouljoud MS, Mulligan DC, Goldstein RM, Husberg BS et al. Quality of life improvements at one, two and five years after liver transplantation. Transplantation 1995; 59: 515-8.
34. National Institutes of Health Consensus Development Conference Statement: liver transplantation - June 20-23, 1983. Hepatology 1983; 4 (suppl 1): 107-10.
35. Consensus Conference on Indication of liver Transplantation. Hepatology 1994; 20 (suppl 1): 1-49.
36. Davies MH, Langman EE, Neuberger JM. Liver disease in a district hospital remote from a transplant centre: a study of admission and deaths. Gut 1992; 33: 1397-9.
37. Benmargstransplantasjon i Norge. Helsedirektoratets utredningsserie 6-1992. Oslo: Statens helsetilsyn (Helsedirektoratet), 1992.